Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luc Dupuis

Showing results (101-110 of 116) with videos related to

Pageof 12
Sort By:
The Lancet. Neurology|June 24, 2018
Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trialAlbert C Ludolph, Joachim Schuster, Johannes Dorst, et al.
Ebiomedicine|March 14, 2023
Metabolic alterations precede neurofilament changes in presymptomatic ALS gene carriersJohannes Dorst, Patrick Weydt, David Brenner, et al.
Nature Communications|March 27, 2025
CREB3 gain of function variants protect against ALSSalim Megat, Christine Marques, Marina Hernán-Godoy, et al.
Medrxiv : the Preprint Server for Health Sciences|June 30, 2025
FUS Mislocalization Rewires a Cortical Gene Network to Drive Cognitive and Behavioral Impairment in ALSRaphaelle Cassel, Félicie Lorenc, Aurélie Bombardier, et al.
European Journal of Neurology|January 19, 2024
In-depth analysis of data from the RAS-ALS study reveals new insights in rasagiline treatment for amyotrophic lateral sclerosisJoachim Schuster, Jens Dreyhaupt, Karla Mönkemöller, et al.
Science Translational Medicine|January 29, 2025
Early-onset sleep alterations found in patients with amyotrophic lateral sclerosis are ameliorated by orexin antagonist in mouse modelsSimon J Guillot, Christina Lang, Marie Simonot, et al.
Human Molecular Genetics|September 3, 2010
A point mutation in the dynein heavy chain gene leads to striatal atrophy and compromises neurite outgrowth of striatal neuronsKerstin E Braunstein, Judith Eschbach, Krisztina Ròna-Vörös, et al.
The EMBO Journal|March 9, 2016
Toxic gain of function from mutant FUS protein is crucial to trigger cell autonomous motor neuron lossJelena Scekic-Zahirovic, Oliver Sendscheid, Hajer El Oussini, et al.
Acta Neuropathologica|April 14, 2023
Loss of hypothalamic MCH decreases food intake in amyotrophic lateral sclerosisMatei Bolborea, Pauline Vercruysse, Tselmen Daria, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 8, 2018
The VAMP-associated protein VAPB is required for cardiac and neuronal pacemaker channel functionNicole Silbernagel, Magdalena Walecki, Martin K-H Schäfer, et al.
Pageof 12

Showing results (101-110 of 116) with videos related to

Sort By:
Pageof 12
The Lancet. Neurology|June 24, 2018
Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trialAlbert C Ludolph, Joachim Schuster, Johannes Dorst, et al.
Ebiomedicine|March 14, 2023
Metabolic alterations precede neurofilament changes in presymptomatic ALS gene carriersJohannes Dorst, Patrick Weydt, David Brenner, et al.
Nature Communications|March 27, 2025
CREB3 gain of function variants protect against ALSSalim Megat, Christine Marques, Marina Hernán-Godoy, et al.
Medrxiv : the Preprint Server for Health Sciences|June 30, 2025
FUS Mislocalization Rewires a Cortical Gene Network to Drive Cognitive and Behavioral Impairment in ALSRaphaelle Cassel, Félicie Lorenc, Aurélie Bombardier, et al.
European Journal of Neurology|January 19, 2024
In-depth analysis of data from the RAS-ALS study reveals new insights in rasagiline treatment for amyotrophic lateral sclerosisJoachim Schuster, Jens Dreyhaupt, Karla Mönkemöller, et al.
Science Translational Medicine|January 29, 2025
Early-onset sleep alterations found in patients with amyotrophic lateral sclerosis are ameliorated by orexin antagonist in mouse modelsSimon J Guillot, Christina Lang, Marie Simonot, et al.
Human Molecular Genetics|September 3, 2010
A point mutation in the dynein heavy chain gene leads to striatal atrophy and compromises neurite outgrowth of striatal neuronsKerstin E Braunstein, Judith Eschbach, Krisztina Ròna-Vörös, et al.
The EMBO Journal|March 9, 2016
Toxic gain of function from mutant FUS protein is crucial to trigger cell autonomous motor neuron lossJelena Scekic-Zahirovic, Oliver Sendscheid, Hajer El Oussini, et al.
Acta Neuropathologica|April 14, 2023
Loss of hypothalamic MCH decreases food intake in amyotrophic lateral sclerosisMatei Bolborea, Pauline Vercruysse, Tselmen Daria, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 8, 2018
The VAMP-associated protein VAPB is required for cardiac and neuronal pacemaker channel functionNicole Silbernagel, Magdalena Walecki, Martin K-H Schäfer, et al.
Pageof 12